Age Related Changes in Calciotropic Hormones and Their Impact on Male Osteoporosis

The purpose of this pilot study is to generate preliminary data regarding the skeletal effects of age-related changes in calcium and vitamin D metabolism in older men.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Low Bone Density Bone Diseases Bone Diseases, Metabolic Metabolic Diseases Musculoskeletal Diseases Nutritional and Metabolic Diseases

Age range

50 year and older

Sex eligibility

Male

Study type

Observational

Primary location

Yale Center for Clinical Investigation

New Haven, Connecticut, 06520, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

healthy men age 50 yrs and older

Exclusion criteria

smokers
known history of metabolic bone disease, known history of hypogonadism or renal insufficiency.

Treatment and study plan

Primary outcomes

Bone density of hip and spine

Time frame: measured after screening evaluation

Secondary outcomes

calciotropic hormones, including calcium, PTH and vitamin D metabolites

Time frame: measured after screening evaluation

Sponsors and collaborators

Lead sponsor

Yale University

Other

Collaborators

National Institute on Aging (NIA)

Registry information

Official study title

Pilot Study to Assess the Skeletal Effects of Age-related Changes in Calcium and Vitamin D Metabolism in Men

Important dates

Study start: 2000
Primary completion: 2002
Study completion: 2008
First posted: Jan 9, 2008
Registry last updated: Aug 30, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed